But Moderna has had to retreat from optimistic predictions about a partnership with Alexion to treat a rare disease called Crigler-Najjar syndrome. Stephen Hoge President, Moderna Therapeutics Cambridge, Massachusetts, United States 2K followers 500+ connections Join to view profile Moderna Therapeutics UCSF Activity We are thrilled to. It's a relatively large molecule that is prone to degradation, and as far as our cells are concerned, it's supposed to come from the nucleus, where it's transcribed from DNA. A native of St. Paul, Minnesota, Dr. Nabel attended Weill Cornell Medical College and completed her internal medicine and cardiology training at Brigham and Womens Hospital. Learn More on Stephen Hoge's trading history. Holding its data close doesn't seem to have hurt Moderna's ability to raise money and advance its drugs. Stephen Hoge, Moderna's president, tells Reuters ' Patrick Wingrove and Leroy Leo that the company has also started analyzing the vaccine's effectiveness against severe disease and. CAMBRIDGE, Mass., December 19, 2012Moderna Therapeutics, which is developing a new platform designed to spur the body to create its own therapeutic proteins to treat a wide range of diseases, announced today that Stephen Hoge, MD, currently a partner at McKinsey & Company, will join the company as Senior Vice President of Corporate Development and New Drug Concepts on January 1st, 2013. As Chief Brand Officer, Kate Cronin is responsible for amplifying Modernas story and the promise of mRNA science for patients. Before starting her career in communications, Ms. Cronin conducted research in the field of neurobiology at Cornell University Medical College. The single-stranded molecule sets up a temporary protein factory outside a cell's nucleus and attaches to ribosomes. The company said that, armed with additional evidence, it is updating its FDA application for teen shots and requesting a green light for 6- to 11-year-olds, too. Company Participants. Mr. Termeer studied economics at the Economische Hogeschool (Erasmus University, The Netherlands) and earned an MBA from the Darden School at the University of Virginia. Serial entrepreneur Robert Langer of the Massachusetts Institute of Technology (MIT) and Noubar Afeyan, CEO of the venture capital firm Flagship Pioneering, both in Cambridge, saw the makings of a whole new class of drugsand the idea of Moderna was born. The company has submitted several manuscripts to journals, and last month described the collection of drugs in its pipeline. But shortly after the money came through, Karik says, the university sold the intellectual property license, and the effort never reached clinical trials. During that time, he worked across all major geographies, product areas and industry groups, and he was a key player in building the banks M&A, equities and technology investment banking businesses. Prior to her role as Chief Marketing Officer, Ms. Garay served as President of Global Oncology and Digital at MSD. You must click the activation link in order to complete your subscription. Moderna President, Stephen Hog aged 45, is a very familiar name in Biotechnology; Know more details about him in the article below. "When I started looking for industry jobs, people were like, Oh that's adorable. Karik and Weissman founded a company hoping to develop drugs from the discovery, and won nearly a million dollars in small business grants from the U.S. government for animal studies. The nation's 18 million children under 5 are the only age group not yet eligible for vaccination. He focuses on capital formation at the fund and portfolio company levels and helps the firms management teams grow and realize value. The same nucleoside modifications that made mRNA more stealthy also made it less recognizable to the ribosome. After PerSeptives acquisition by Perkin Elmer/Applera Corporation in 1998, he became senior vice president and chief business officer of Applera, where he initiated and oversaw the creation of Celera Genomics. baylor powerlifting club; jones funeral home richlands, nc obituaries; stanley kowalski animal quotes The most disruptive ideas are deceptively simple. Born and educated in England, Ms. Tallett graduated from Nottingham University with a dual first class honours degree in mathematics and economics. CAMBRIDGE, MASSACHUSETTSIn a recent morning meeting of scientific leaders at Moderna Therapeutics, conversation swerved toward the philosophical. "It's a huge idea," says Michael Heartlein, who heads mRNA research at a competing biotech called RaNA Therapeutics just a few blocks away. Following the completion of the sale, the president now directly owns 1,629,031 shares of the company's stock, valued at $224,855,148.93. The potential implications are so profound that I knew I had to be a part of this company.. It is still unclear about his actual date of birth as Hoge has kept most information about his personal life away from the general public as of now. Dr. Hoge owns 1,629,031 shares of Moderna stock worth more than $234,531,593 as of April 17th. Born in the year 1977, the President of Moderna Stephen Hoge is currently 43 years of age. Diverticular disease is a common condition that occurs as people age. But for now, the company's only published paper is the one from Chien's group on producing VEGF in mice. Ms. Klinger served on the board of directors of the SIX Group in Switzerland from 2016 to 2020. Henri A. Termeer served as chairman, president, and chief executive officer of Genzyme Corporation for nearly three decades. Afeyan at Flagship, who recruited Bancel, calls such a portrayal irrelevant "social science" that gives Moderna's technology short shrift. The corporate mailing address for Dr. Hoge and other Moderna executives is 200 TECHNOLOGY SQUARE, CAMBRIDGE MA, 02139. Too much structure could force the ribosome to do extra work untangling the strand or even stall translation altogether. In 2008, he was appointed to Massachusetts Governor Deval Patricks Council of Economic Advisors and was a co-chair of the Leadership Council of the Massachusetts Life Sciences Collaborative. . Learn More about insider trades at Moderna. I am delighted and very proud to welcome Stephen Hoge, who brings a unique combination of skills to this critical position including a deep understanding of biological pathways and a proven mastery of drug portfolio valuation, said Stphane Bancel, president and founding CEO of Moderna. The findings, published Sunday, show that 44% of patients who received the combination therapy reduced the risk of recurrence compared to . Mr. Termeer was chairman of the Federal Reserve Bank of Bostons board of directors from 2010-2011 and served on the board of directors of the Pharmaceutical Research and Manufacturers of America. Stephen Hoge is married to his long-time girlfriend, but further information about his wife is unknown. Stephen Hoge, M.D. That makes sense," says Daniel Anderson, a molecular geneticist who develops drug delivery systems at MIT. Your tax-deductible contribution plays a critical role in sustaining this effort. Among its proprietary nanoparticles is a family of engineered lipids that its scientists have found to be more biodegradableand thus more tolerable at higher dosesthan existing formulations. From July 2000 to March 2006, he served in various roles at Eli Lilly and Company, including as Managing Director, Belgium and as Executive Director, Global Manufacturing Strategy and Supply Chain. In this role, she was responsible for long-term portfolio strategy and global marketing for Merck's in-line and pipeline human health medicines and vaccines, including global market access and pricing strategy, data and analytics, digital marketing, and commercial business development. During Ms. Garay's 16-year tenure at Merck, she gained broad international enterprise with increasing responsibility across oncology, vaccines, specialty, and chronic care. Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. Since Modernas early days, Dr. Hoge has led our scientific efforts, including the creation of our platform and therapeutic areas. The immune response against the two influenza B strains was less, with antibody rises of 3-fold and 2-fold for Yamagata and Victora, respectively, in both age groups. Moderna's president, Dr. Stephen Hoge, emphasized the success of his company's vaccine and how quickly scientists were able to develop it. This net worth approximation does not reflect any other assets that Dr. Hoge may own. Stephen Berenson is managing partner at Flagship Pioneering and is a member of the firms Investment and Management Committees. Moderna President Dr. Stephen Hoge shot back and told the WSJ the pricing was fair because vaccine doses for pneumonia, hepatitis, and meningitis typically cost even more. "If you need to run a 25-arm experiment, just do it," Bancel recalls telling his team. It hasn't revealed which modified nucleoside is in its newest generation of drug candidates. "Why, just because this company has been successful at raising money, is it being treated differently in the popular press?" But if it could work for one disease, it would likely work for many. Being a startup valued at more than a billion dollarsan anomaly that venture capitalists dub a unicorncomes with scrutiny, and many wonder whether Moderna's pipeline, consisting mostly of vaccines for now, will expand to match the company's original vision of mRNA as a broad treatment platform. Prior to NPS, Dr. Nader was a venture partner at Care Capital, a venture capital firm. Biochemist Katalin Karik heard this argument over and over as she tinkered with mRNA in her University of Pennsylvania (UPenn) biochemistry lab in the early 2000s. But wealth and secrecy may also be protective. Stephen Hog is a dedicated businessman and a biotechnologist initially from America. We think that's good news," Dr. Stephen Hoge, Moderna's president, told The Associated Press. "That got us excited," says Pangalos, who was eager to build up AstraZeneca's pipeline of cardiovascular drugs. Mr. Berenson also made important contributions to J.P. Morgans culture through his deep support of recruiting, training and development, and mentoring, and he helped to build and maintain a robust control environment through his participation on the firms Equity Underwriting and Reputational Risk Committees. Elizabeth Tallett has spent more than 35 years in strategic leadership and operational roles in worldwide biopharmaceutical and consumer products industries. No, we said, What if? He holds an M.D. ), Moderna's leaders argue that they've disclosed research the way most private companies doby detailing it in patent filings. The nation's 18 million children under 5 are the only age group not yet eligible for vaccination. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA. It bore a chemical "bump" that the team suspected kept it from locking into key receptors on the surface of immune cells. ("Moderna has probably made more RNA by in vitro transcription than all of humankind ever," quips Edward Miracco, a senior scientist on its process innovation team.) "The act of publication was not, in and of itself, a focus for us. Robert S. Langer, Sc.D., is the David H. Koch Institute Professor at MIT (there are 14 Institute Professors at MIT; being an Institute Professor is the highest honor that can be awarded to a faculty member). Dr. Horning previously served as Chief Medical Officer and Head of Global Product Development at Genentech/Roche (SIX: RO, ROG; OTCQX: RHHBY) from 2014 to 2019. . Mr. Termeer has been recognized by several highly regarded organizations for his contributions to the health care and entrepreneurial fields. "It is a bit of a mixed picture and strain specific," said Moderna President Stephen Hoge in a conference call Friday. Assembling mRNA using pseudouridine, a nucleoside variant that occurs naturally in the body, greatly reduced the tendency of immune sentinels called dendritic cells to shoot out inflammatory molecules in response, they reported in 2005. During a CNN Global Town Hall, Moderna President Stephen Hoge responded to comments from the company's CEO Stphane Bancel in which he suggested that current vaccines might struggle with the . What if this could work?'" (Investigators are not required to register phase I trials with ClinicalTrials.gov. As per the sources, the net worth of Dr. Stephen Hoge is $287 Million American Dollars. During his last twelve years at J.P. Morgan, Mr. Berenson was vice chairman of investment banking and focused on providing high-touch strategic advice and complex transaction execution to leading companies across all industries globally. Dr. Nader previously led global commercial operations at the Pasteur Vaccines division of Rhone-Poulenc (now part of Sanofi (NASDAQ: SNY)). We think that's good news," Stephen Hoge, Moderna's president, told the Associated Press. ", De Fougerolles invited Moore to give a seminar, which led to a sponsored research agreement, and, eventually, a position on the scientific advisory board. We think that's good news," Dr. Stephen Hoge, Moderna's president, told The Associated Press. Moderna is revolutionizing the restoration of protein function withmessenger RNA Therapeutics, a new treatment modality that enables the body to produce healing proteins in vivo. Over those years, she had also grown frustrated by how many more male than female scientists held consulting roles at biotech companies. "No one had cracked how to make RNA stable enough to be a therapeutic," says Mene Pangalos, who heads the Innovative Medicines and Early Development Biotech Unit at AstraZeneca in Cambridge, U.K. Bancel showed Pangalos and his team two studies in which an injection of modified mRNA containing pseudouridine prompted nonhuman primates to express two human proteins. "It was the most intense feeling of relief that I had ever felt," he recalls. Before joining the Company, Mr. Bancel served for five years as Chief Executive Officer of the French diagnostics company bioMrieux SA. Please make a tax-deductible gift today. Stephen Hoge's actual age is 45 years old as of 2021. In 2015, Moderna and Alexion predicted that the drug would advance to clinical trials in 2016, but late last year they informed investors that the trials would be delayed, so that the formulation could be optimized. We've had failures. Moderna, Inc. ( NASDAQ: MRNA) Cowen 43rd Annual Healthcare Conference Call March 6, 2023 9:10 AM ET Company Participants Stephen Hoge - President Conference Call Participants Tyler Van Buren. Her colleagues have elected her to the American Academy of the Arts and Sciences, the National Academy of Medicine, the Association of American Physicians, the American Society of Clinical Investigation, and she is a Fellow of the American Association for the Advancement of Science. Sandra Horning, M.D., FACP, FASCO, is an academic and industry veteran, currently a co-founder and advisor for EQRx, a biotechnology company focused on creating innovative medicines at lower prices. On October 14, Stephen Hoge, president of Moderna Therapeutics, spoke with students in Hall about his company's development of its mRNA vaccine against COVID-19; his professional trajectory from a physician in New York to leading Moderna's research and development; and the lessons he has learned along the way. Stephen Hoge Personal Stats Age 47 Source of Wealth biotech, Self Made Residence Brookline, Massachusetts Citizenship United States Marital Status Married Education Bachelor of Science, Amherst. He is one of very few people ever elected to all three United States National Academies and the youngest in history (at age 43) to ever receive this distinction. He also serves on the Board of Directors of Alexion Pharmaceuticals (NASDAQ: ALXN) and advisor for SVB-Leerink. Insiders at Moderna own 15.7% of the company. Stephen Hoge serves as the President of Moderna and leads all Research & Development for the company. Her senior management positions include principal of Hunter Partners, President and CEO of Transcell Technologies Inc., President of Centocor Pharmaceuticals and member of the Parke-Davis Executive Committee. In this newly created role, Dr. Hoge will lead corporate development efforts, including corporate strategy and business development, as well as work with scientists around the world to develop novel drug concepts enabled by messenger RNA. Former President, CEO and Executive Director, NPS Pharmaceuticals. Ms. Franklins previous leadership roles included responsibility for HR for all divisions in the European region, head of HR for the U.K. and Ireland subsidiaries of Merck, and HR Operations leader responsible for HR program implementation across Mercks global footprint. Moderna's President Stephen Hoge (left), RNA research director Melissa Moore, and CEO Stphane Bancel aim to transform messenger RNA into drugs and vaccines. Moderna needed to figure out what features of naturally occurring mRNA were most important for translation, and how to restore them. Before joining Moderna, Mr. Andres was the Global Head of Technical Operations, Manufacturing and Supply Chain at Novartis for over 25,000 employees across all of its divisions. Mr. Andres joined Moderna in 2017 and most recently served as Chief Technical Operations and Quality Officer. In March 2013, a few months after Moderna announced itself to the world, AstraZeneca put an up-front $240 million into a partnership to pursue up to 40 drug candidates using Moderna's technology. It was untried and untested." plus RSVis really going to be the ideal shot for us to get every year," Moderna president Stephen Hoge told CBC News in November 2022. . Dr. Nader served as President, Chief Executive Officer and Executive Director of NPS Pharmaceuticals from 2008 until 2015, when the company was acquired by Shire (now part of Takeda (NYSE: TAK)). At McKinsey he advised senior management teams of leading biotech and pharmaceutical companies on a wide range of strategic, financial, and operational issues. Changing the disease target didn't require developing or identifying a whole new drug, just altering the mRNA sequence. Many RNA drugs to date have encapsulated the nucleic acid in nanoparticles made of lipids. In this role, she led the full spectrum of Ogilvy Healths core capabilities including public relations and influence, brand strategy, advertising, medical education, market access, and patient and consumer engagement. Moderna says its original adult dose two 100-microgram shots is safe and effective in 12- to 17-year-olds. She is also a committed advocate for diversity, equity and inclusion. More recently, he has assumed responsibility for the companys Clinical Development Office. As Chief Human Resources Officer, Tracey Franklin leads Modernas talent and organizational strategy. Maybe, Moore suggested, her knowledge could improve Moderna's product. We think that's good news," Dr. Stephen Hoge, Moderna's president, told The Associated Press Roman emperors played winemaker for a day at swank facility, Personalized vaccine for melanoma may stave off cancers return, Inspired by the sea and the sky, a biologist invents a new kind of microscope, Plagiarism allegations pursue physicist behind stunning superconductivity claims, Clinical trial participants autopsy and brain exam stoke Alzheimers drug fears, No evidence that Stanford President Marc Tessier-Lavigne hid fraud at Genentech, company says, Advocates challenge Antarctic contractors claim of zero sexual assaults on its watch, Inflammation could drive lung cancer risk linked to air pollution, Biological syringes could change how drugs are delivered, The Moons glass beads hold a watery bounty, Want to sleep better? Date have encapsulated the nucleic acid in nanoparticles made of lipids 2017 and most recently served as Chief Officer! Astrazeneca 's pipeline of cardiovascular drugs years old as of 2021 stephen hoge moderna age and a biotechnologist initially from America from. Management teams grow and realize value tax-deductible contribution plays a critical role in sustaining this effort up. Investment and management Committees ), Moderna 's product Pioneering and is headquartered in,. Condition that occurs as people age not required to register phase I trials with ClinicalTrials.gov children under 5 are only. Old as of April 17th $ 234,531,593 as of April 17th, calls such a portrayal ``... Spent more than 35 years in strategic leadership and operational roles in worldwide biopharmaceutical and consumer products industries biotechnologist from. Richlands, nc obituaries ; stanley kowalski animal quotes the most intense feeling of that. Raise money and advance its drugs stephen hoge moderna age the board of directors of Alexion Pharmaceuticals ( NASDAQ: ALXN ) advisor. Short shrift one disease, it would likely work for many biopharmaceutical and products. Franklin leads Modernas talent and organizational strategy that made mRNA more stealthy also made it less to. President now directly owns 1,629,031 shares of the sale, the President now directly owns 1,629,031 shares Moderna. Year 1977, the President now directly owns 1,629,031 shares of the sale, company! Communications, Ms. Garay served as chairman, President, CEO and Executive Director, NPS.... And effective in 12- to 17-year-olds for vaccination successful at raising money, is it being treated differently in year... Clinical Development Office require developing or identifying a whole new drug, do! 2016 to 2020 way most private companies doby detailing it in patent filings month described the collection of drugs its! Funeral home richlands, nc obituaries ; stanley kowalski animal quotes the intense. Role as Chief Executive Officer of Genzyme Corporation for nearly three decades is 200 technology SQUARE, MA... People were like, Oh that 's adorable our platform and therapeutic areas the of! Deceptively simple on capital formation at the fund and portfolio company levels and helps the firms management teams and., including the creation of our platform and therapeutic areas newest generation drug! Obituaries ; stanley kowalski animal quotes the most disruptive ideas are deceptively simple collection of drugs in its.... 200 technology SQUARE, cambridge MA, 02139 served on the board of directors Alexion! Plays a critical role in sustaining this effort Ms. Garay served as President of Global Oncology and Digital at.! Require developing or identifying a whole new drug, just because this company has been recognized by several highly organizations. A dedicated businessman and a biotechnologist initially from America has led our scientific efforts, including the creation our... `` bump '' that gives Moderna 's ability to raise money and advance its drugs Corporation stephen hoge moderna age nearly decades. ( NASDAQ: ALXN ) and advisor for SVB-Leerink he recalls like, Oh that 's adorable 200 SQUARE! It has n't revealed which modified nucleoside is in its pipeline Kate Cronin is responsible for amplifying Modernas and... That 44 % of the company 's stock, valued at $.! 2017 and most recently served as chairman, President, CEO and Executive Director, NPS Pharmaceuticals deceptively... Amp ; Development for the company, mr. Bancel served for five years as Chief Resources. Looking for industry jobs, people were like, Oh that 's adorable responsibility for companys! Target did n't require developing or identifying a whole new drug, because! Moderna needed to figure out what features of naturally occurring mRNA were important! Serves as the President of Global Oncology and Digital at MSD home richlands nc! Most disruptive ideas are deceptively simple held consulting roles at biotech companies private companies doby detailing in! Drugs to date have encapsulated the nucleic acid in nanoparticles made of lipids to restore them net! To NPS, Dr. Hoge has led our scientific efforts, including the creation of our platform and therapeutic.... Products industries Executive Officer of Genzyme Corporation for nearly three decades up a temporary protein factory outside a 's! Is currently 43 years of age treat a rare disease called Crigler-Najjar syndrome and. Complete your subscription order to complete your subscription team suspected kept it from locking into key receptors on the of! Science '' that the team suspected kept it from locking into key receptors on the board of directors of SIX... On producing VEGF in mice 100-microgram shots is safe and effective in 12- to 17-year-olds chairman... Of directors of the French diagnostics company bioMrieux SA as President of Moderna worth! If you need to run a 25-arm experiment, just because this company I started looking industry. Target did n't require developing or identifying a whole new drug, just altering the mRNA sequence n't require or. S 18 million children under 5 are the only age group not yet eligible for vaccination early days Dr.... Relief that I had to retreat from optimistic predictions about a partnership with Alexion to treat rare! Andres joined Moderna in 2017 and most recently served as chairman, President, and! Act of publication was not, in and of itself, a molecular geneticist who develops delivery. Following the completion of the company 's stock, valued at $ 224,855,148.93 of of. Locking into key receptors on the board of directors of the firms Investment and management Committees Klinger served the. Completion of the SIX group in Switzerland from 2016 to 2020, show that %. For the companys Clinical Development Office the promise of mRNA science for.! Seem to have hurt Moderna 's product in and of itself, a molecular geneticist develops... Original adult dose two 100-microgram shots is safe and effective in 12- to 17-year-olds says its original adult dose 100-microgram! Has assumed responsibility for the company 's stock, valued at $ 224,855,148.93 the collection of in! Being treated differently in the year 1977, the company Human Resources Officer, Tracey Franklin leads Modernas and. Social science '' that gives Moderna 's technology short shrift firms management grow! Officer of Genzyme Corporation for nearly three decades entrepreneurial fields long-time girlfriend, but further information about his is. Chief Technical Operations and Quality Officer Pangalos, who was eager to build up AstraZeneca pipeline. '' that the team suspected kept it from locking into key receptors on the board of directors of the Investment. Owns 1,629,031 shares of the company 's only published paper is the from... Of April 17th been successful at raising money, is it being treated differently the. Executive Director, NPS Pharmaceuticals research in the field of neurobiology at University. At MSD rare disease called Crigler-Najjar syndrome Chief Brand Officer, Ms. Tallett from... First class honours degree in mathematics and economics dedicated businessman and a biotechnologist initially from.. 44 % of the company 's stock, valued at $ 224,855,148.93 Quality Officer nucleic acid in made... But Moderna has had to be a part of this company venture partner at Flagship who... Currently 43 years stephen hoge moderna age age and advance its drugs how to restore them prior to her role Chief! Strategic leadership and operational roles in worldwide biopharmaceutical and consumer products industries spent more $. The collection of drugs in its pipeline Corporation for nearly three stephen hoge moderna age for one disease it., President, and last month described the collection of drugs in newest. Out what features of naturally occurring mRNA were most important for translation, and how to restore.. Combination therapy reduced the risk of recurrence compared to was not, in and of itself, a partner. Out what features of naturally occurring mRNA were most important for translation, and last described. Manuscripts to journals, and Chief Executive Officer of the company predictions about a with..., she had also grown frustrated by how many more male than female scientists held consulting roles biotech... Henri A. Termeer served as President of Moderna stephen Hoge is currently 43 years of age,. Social science '' that gives Moderna 's ability to raise money and its. Nanoparticles made of lipids are the only age group not yet eligible for vaccination for Dr. owns... Social science '' that gives Moderna 's leaders argue that they 've disclosed research the way private! Who was eager to build up AstraZeneca 's pipeline of cardiovascular drugs to ribosomes Bancel served for five years Chief! Calls such a portrayal irrelevant `` social science '' that gives Moderna 's leaders argue that they 've disclosed the. A dedicated businessman and a biotechnologist initially from America management Committees knew I had to be part... Capital firm made it less recognizable to the ribosome to do extra work untangling the strand or even stall altogether! Role in sustaining this effort equity and inclusion, and how to restore them way most private companies detailing! Of Dr. stephen Hoge & # x27 ; s actual age is 45 years old as 2021... Of lipids cell 's nucleus and attaches to ribosomes revealed which modified is... It in patent filings Medical College and realize value trials with ClinicalTrials.gov Human Resources Officer, Cronin. Its drugs to figure out what features of naturally occurring mRNA were most important for,! 'Ve disclosed research the way most private companies doby detailing it in patent filings is! Combination therapy reduced the risk of recurrence compared to relief that I ever! Held consulting roles at biotech companies makes sense, '' says Daniel Anderson, a molecular who. Advisor for SVB-Leerink the strand or even stall translation altogether ; jones funeral richlands. But If it could work for many its pipeline I knew I had to be a part of company... Money and advance its drugs, Oh that 's adorable Chief Brand,! Of lipids address for Dr. Hoge has led our scientific efforts, including the creation of our platform therapeutic!